What is the Y-tunnus number of Nephrocare Suomi Oy?

Nephrocare Suomi Oy is registered with PRH / YTJ under Y-tunnus 2961693-3.

What is the revenue of Nephrocare Suomi Oy?

Nephrocare Suomi Oy reported revenue of EUR 5M in 2024.

Who is the CEO of Nephrocare Suomi Oy?

Tiina Annika Puukkoniemi is Audit of Nephrocare Suomi Oy, in role since 2020.

Who is the chairman of Nephrocare Suomi Oy?

Kati Anita Karvinen chairs the board of Nephrocare Suomi Oy, in role since 2023.

Where is Nephrocare Suomi Oy headquartered?

Nephrocare Suomi Oy's registered address is Takomotie 1.

Riskpilot← Back to search

Sign inGet full access

Nephrocare Suomi Oy

OYDissolved

Y-tunnus 2961693-3Takomotie 1, 00380 HelsinkiWholesale of pharmaceutical and medical goods · NACE 4646Est. 2018— employees

Overview Financials People & ownership Related companies

Financials

Revenue

EUR millions

EBITDA

EUR millions

Income statement

EUR thousands

Item	2020	2021	2022	2023	2024
Revenue	3 677	3 625	3 620	4 646	4 990
Staff expenses	−2 405	−2 460	−2 813	−2 732	−2 097
EBITDA	−1 421	−1 472	−1 746	−889	703
Depreciation & amort.	−689	−698	−697	−694	−263
EBIT	−2 109	−2 171	−2 443	−1 584	440
Net financials	−19	−32	−44	−110	−96
Profit before tax	−128	−1 703	−2 487	−1 694	344
Tax	−0	−0	−0	−0	−0
Net profit	−128	−1 703	−2 487	−1 694	344

Balance sheet

EUR thousands

Item	2020	2021	2022	2023	2024
Total assets	6 916	3 662	2 444	2 117	931
Equity	2 176	473	−2 014	−1 608	−1 264
Long-term debt	—	—	—	0	0
Short-term debt	4 740	3 189	4 458	757	79
Total debt	4 740	3 189	4 458	757	2 195

Financial ratios

5-year trend

EBITDA margin

14.1%

This company

15.8%

Market median

-11% vs market

20202024

Equity ratio

-135.7%

This company

38.2%

Market median

-455% vs market

20202024

Return on equity

34382600.0%

This company

18.4%

Market median

+186861857% vs market

20202024

Net profit margin

6.9%

This company

8.1%

Market median

-15% vs market

20202024

Asset turnover

5.36×

This company

1.12×

Market median

+379% vs market

20202024

Debt / equity

1.74×

This company

0.62×

Market median

-181% vs market

20202024

Annual reports & filings

Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View PDF

Nephrocare Suomi Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Nephrocare Suomi Oy

Financials

Revenue

EBITDA

Income statement

Balance sheet

Financial ratios

Annual reports & filings

More on Nephrocare Suomi Oy